The demand for advanced diagnostic imaging in India is rising, supported by a large population base, increasing prevalence of complex diseases across multiple specialties, and limited access to high-end imaging infrastructure. Against this backdrop, the magnetic resonance imaging (MRI) systems market in India is projected to grow at a 12% compound annual growth rate (CAGR) between 2026 and 2036, forecasts GlobalData, a leading intelligence and productivity platform.

GlobalData’s report, “Magnetic Resonance Imaging (MRI) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” reveals that India accounted for 22% of the Asia–Pacific (APAC) MRI systems market in 2025.

Hyperfine, a US-based medical technology company, has recently obtained regulatory approval from India’s Central Drugs Standard Control Organization (CDSCO) for its Swoop portable MRI system. The commercial rollout of the system is anticipated in early 2026.

Swoop is the first US FDA-cleared, AI-powered portable MRI designed for brain imaging, and the approval is expected to improve access to advanced neuroimaging across India. The system will be introduced in the Indian market through a partnership with Radiosurgery Global (RSG), a medical device distributor with a strong nationwide healthcare network.

Nidhi Bharti, Medical Devices Analyst at GlobalData, comments: “The next phase of MRI adoption in India is less about adding capacity in major hospitals and more about changing where and when imaging can take place. Earlier MRI systems concentrated diagnostic services in a limited number of high-end centers, often delaying scans for acute or high-risk patients.

“Newer MRI systems enable imaging to be performed closer to the point of care, supporting faster clinical decisions in emergency, critical care, and step-down settings, which is expected to reduce reliance on patient transfers, improve coordination between clinicians and radiology teams, and allow healthcare providers to manage neurological conditions with greater speed and consistency than was previously possible.”

The partnership between Hyperfine and RSG combines advanced MRI technology with local market expertise, regulatory understanding, and distribution strength. This partnership is expected to facilitate the introduction of mobile, lower-infrastructure MRI systems with AI-supported image quality across a wider range of hospitals and care centers, including locations where conventional MRI installations are not feasible.

Bharti concludes: “As portable MRI systems gain wider adoption in India, they are expected to reduce missed diagnoses and deliver results faster, helping patients move through treatment more smoothly. As they are easier to install and can be deployed more widely, these innovations can also bolster government efforts to strengthen healthcare delivery and expand access to high-quality diagnostic services across the country.”